These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22294704)

  • 1. Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial.
    Tsang Y; Venables K; Yarnold J;
    Br J Radiol; 2012 Sep; 85(1017):e647-53. PubMed ID: 22294704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer.
    Winfield EA; Deighton A; Venables K; Hoskin PJ; Aird EG;
    Br J Radiol; 2003 Apr; 76(904):254-9. PubMed ID: 12711645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.
    Wills L; Maggs R; Lewis G; Jones G; Nixon L; Staffurth J; Crosby T;
    Radiat Oncol; 2017 Nov; 12(1):179. PubMed ID: 29141663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.
    Tsang Y; Ciurlionis L; Kirby AM; Locke I; Venables K; Yarnold JR; Titley J; Bliss J; Coles CE;
    Br J Radiol; 2015; 88(1056):20150453. PubMed ID: 26492402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of UK breast radiotherapy techniques: background prior to the introduction of the quality assurance programme for the START (standardisation of radiotherapy) trial in breast cancer.
    Winfield E; Deighton A; Venables K; Hoskin PJ; Aird EG
    Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):267-71. PubMed ID: 12206636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review.
    Ataman F; Poortmans P; Stupp R; Fisher B; Mirimanoff RO
    Eur J Cancer; 2004 Jul; 40(11):1724-30. PubMed ID: 15251162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.
    Naismith O; Mayles H; Bidmead M; Clark CH; Gulliford S; Hassan S; Khoo V; Roberts K; South C; Hall E; Dearnaley D;
    Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):611-620. PubMed ID: 31201110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.
    Versteijne E; Lens E; van der Horst A; Bel A; Visser J; Punt CJA; Suker M; van Eijck CHJ; van Tienhoven G
    Strahlenther Onkol; 2017 Aug; 193(8):630-638. PubMed ID: 28608305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
    Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
    Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation.
    Kaidar-Person O; Nissen HD; Yates ES; Andersen K; Boersma LJ; Boye K; Canter R; Costa E; Daniel S; Hol S; Jensen I; Lorenzen EL; Mjaaland I; Nielsen MEK; Poortmans P; Vikström J; Webb J; Offersen BV
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):20-29. PubMed ID: 32988717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance for a multicenter Phase II study of stereotactic ablative radiotherapy for hepatocellular carcinoma ≤5 cm: a planning dummy run.
    Bae SH; Kim MS; Jang WI; Kim KB; Cho KH; Kim WC; Lee CY; Kim ES; Choi CW; Chang AR; Jo S; Kim JY
    Jpn J Clin Oncol; 2017 Jun; 47(6):535-542. PubMed ID: 28419246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
    ; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR
    Lancet Oncol; 2008 Apr; 9(4):331-41. PubMed ID: 18356109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of the ISC technique for breast cancer radiotherapy and comparison with clinical recommendations.
    Flejmer AM; Josefsson D; Nilsson M; Stenmarker M; Dasu A
    Anticancer Res; 2014 Jul; 34(7):3563-8. PubMed ID: 24982370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the effect of intrafraction motion during breast IMRT planning and dose delivery.
    George R; Keall PJ; Kini VR; Vedam SS; Siebers JV; Wu Q; Lauterbach MH; Arthur DW; Mohan R
    Med Phys; 2003 Apr; 30(4):552-62. PubMed ID: 12722807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Danish Breast Cancer Group locoregional radiotherapy guideline adherence in clinical treatment data 2008-2016: The DBCG RT Nation study.
    Refsgaard L; Skarsø Buhl E; Yates E; Maae E; Berg M; Al-Rawi S; Saini A; Vestmø Maraldo M; Boye K; Louise Holm Milo M; Jensen I; Wichmann Matthiessen L; Nørring Bekke S; Holck Nielsen M; Laugaard Lorenzen E; Bech Jellesmark Thorsen L; Sofia Korreman S; Vrou Offersen B
    Radiother Oncol; 2024 Oct; 199():110289. PubMed ID: 38944554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implementation of intensity-modulated tangential beam irradiation for breast cancer.
    Li JS; Freedman GM; Price R; Wang L; Anderson P; Chen L; Xiong W; Yang J; Pollack A; Ma CM
    Med Phys; 2004 May; 31(5):1023-31. PubMed ID: 15191288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run.
    Valley JF; Bernier J; Tercier PA; Fogliata-Cozzi A; Rosset A; Garavaglia G; Mirimanoff RO
    Radiother Oncol; 1998 Apr; 47(1):37-44. PubMed ID: 9632290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy.
    Tsang Y; Haviland J; Venables K; Yarnold J;
    Radiother Oncol; 2012 Aug; 104(2):143-7. PubMed ID: 22809586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.